Screener
Monte Rosa Therapeutics, Inc. GLUE Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
FAQ
- What is Monte Rosa Therapeutics, Inc.'s total assets?
- Monte Rosa Therapeutics, Inc. (GLUE) reported total assets of $691.16M in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s total assets changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s total assets increased by 92.2% year-over-year, from $359.59M to $691.16M.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Monte Rosa Therapeutics, Inc.'s total assets has grown at a 55.5% compound annual growth rate (CAGR), from $49.38M to $448.66M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Monte Rosa Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude